Which has the lower trailing P/E, CHE or TMDX?

TMDX has the lower trailing P/E: CHE trades at 26.12 and TMDX at 23.77. P/E is one valuation measure and does not by itself establish which business is cheaper.

Which has grown faster, CHE or TMDX?

Over the past five years, TMDX grew revenue faster — CHE at a 4.12% CAGR versus TMDX at 86.12%.

Does CHE or TMDX pay a bigger dividend?

CHE pays a dividend (0.48% yield), while TMDX has no payments in the available dividend history.

Is CHE or TMDX more profitable?

TMDX runs the higher net margin — CHE at 10.60% versus TMDX at 22.69%.

How have CHE and TMDX total returns compared?

Over the past 5 years, CHE delivered 15.15% and TMDX delivered 23.54% annualized total return. Past performance doesn't predict future results.

Chemed Corporation (CHE) vs TransMedics Group, Inc. (TMDX)

A side-by-side comparison of Chemed Corporation and TransMedics Group, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of August 28, 2026. Differences are shown without an overall score or investment verdict.

CHE

Chemed Corporation

$6.80B

$520.27HealthcareDelayed quote: Aug 27, 2026, 4:00 PM EDT

TMDX

TransMedics Group, Inc.

$3.17B

$91.75HealthcareDelayed quote: Aug 27, 2026, 4:00 PM EDT

Total return — CHE vs TMDX

growth of $100 · dividends reinvested · last 7y

CHE +63.4% (+7.3%/yr)TMDX +310.3% (+22.3%/yr)TMDX compounded faster over this window

CHE TMDX

CHE vs TMDX: by the numbers

•CHE is the larger company ($6.80B vs $3.17B market cap).
•TMDX trades at the lower trailing earnings multiple (23.77 vs 26.12 P/E), one valuation lens rather than an overall verdict.
•TMDX converts more revenue to profit (22.69% vs 10.60% net margin).
•TMDX grew revenue faster over the past five years (86.12% vs 4.12% CAGR).
•CHE pays a dividend (0.48% yield), while TMDX has no payments in the available dividend history.

Metrics side by side

Valuation

Metric	CHE	TMDX
P/E ratio	26.12	23.77
Forward P/E	20.38	61.33
P/S ratio	2.69	5.59
P/B ratio	8.41	7.21
EV / EBITDA	17.50	34.99
FCF yield	4.63%	2.12%

Profitability

Metric	CHE	TMDX
Gross margin	30.44%	58.69%
Operating margin	13.46%	12.21%
Net margin	10.60%	22.69%
ROE	33.11%	29.28%
ROIC	19.48%	5.87%

Dividends

Metric	CHE	TMDX
Dividend yield	0.48%	N/A
Payout ratio	13.57%	N/A

Growth (annualized)

Metric	CHE	TMDX
Revenue CAGR (5Y)	4.12%	86.12%
EPS CAGR (5Y)	-1.65%	N/A
FCF CAGR (5Y)	-5.44%	N/A
Total return CAGR (5Y)	2.27%	23.54%

Frequently asked

Which has the lower trailing P/E, CHE or TMDX?: TMDX has the lower trailing P/E: CHE trades at 26.12 and TMDX at 23.77. P/E is one valuation measure and does not by itself establish which business is cheaper.
Which has grown faster, CHE or TMDX?: Over the past five years, TMDX grew revenue faster — CHE at a 4.12% CAGR versus TMDX at 86.12%.
Does CHE or TMDX pay a bigger dividend?: CHE pays a dividend (0.48% yield), while TMDX has no payments in the available dividend history.
Is CHE or TMDX more profitable?: TMDX runs the higher net margin — CHE at 10.60% versus TMDX at 22.69%.
How have CHE and TMDX total returns compared?: Over the past 5 years, CHE delivered 15.15% and TMDX delivered 23.54% annualized total return. Past performance doesn't predict future results.

Go deeper

Full CHE analysis Full TMDX analysis Interactive comparison tool

Dig into the metrics

Chemed P/E ratio TransMedics P/E ratio Chemed dividend yield Chemed ROE TransMedics ROE Chemed operating margin TransMedics operating margin Chemed revenue growth TransMedics revenue growth Chemed free cash flow TransMedics free cash flow

Chemed & TransMedics appear in these rankings

Fastest Revenue Growth Stocks Highest ROE Stocks Highest ROIC Stocks Highest FCF Yield Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified August 28, 2026.